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threatening drug–drug interaction.2 Effective treatment of
leflunomide-induced interstitial lung disease using chole-
styramine washout therapy has been reported. Eleven days
of 8 g of cholestyramine three times daily is recommended
to reverse effects of leflunomide; otherwise the long elimi-
nation half-life of 1 to 4 weeks make it impossible to
detect subtherapeutic plasma levels for 2 years.3 Alterna-
tive management might be the use of target-specific oral
anticoagulants (TSOACs) instead of warfarin. It would
probably have been a rational approach in the current case
to switch to TSOACs because of their lack of leflunomide
interaction, but this would have been a major challenge
when absence of antidotes for TSOACs was considered in
the case of gastrointestinal bleeding in such a high-risk
individual. Low-molecular-weight heparin was started as a
trusted method of anticoagulation. In conclusion, it was
challenging to determine the best agent to maintain antico-
agulation. Physicians should keep in mind that many fac-
tors influence warfarin metabolism and that alternative
agents may be beneficial in selected cases.
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AN UNUSUAL CASE OF HEMIBALLISM-
HEMICHOREA ASSOCIATED WITH NONKETOTIC
HYPERGLYCEMIA IN ASSOCIATION WITH A
CENTRUM SEMIOVALE STROKE
To the Editor: An 86-year-old man with a medical history
of diabetes mellitus, hypertension, dyslipidemia, severe
tobacco use (10 pack-years), and brain trauma was admit-
ted to the hospital for a left-sided hemichoreoathetosis that
had started suddenly 48 hours before. Family history was
unremarkable for movement disorders.
On neurological examination, he was disoriented to
time and space and presented with left-sided abnormal
involuntary movements suggestive of hemichoreoathetosis
associated with left facial spasms.
Brain computed tomography (CT) revealed spontane-
ous hyperdensity within the right striatum. Blood sample
examination showed high fasting glucose (306 mg/dL, nor-
mal <126 mg/dL), high glycosylated hemoglobin (HbA1c;
11.9%, normal <6.5%), and high osmolarity (303.3 mO-
smol/kg, normal 285–295 mOsmol/kg); urinary ketones
were absent; and cerebrospinal fluid analysis revealed high
glucose and lactate levels. On brain magnetic resonance
imaging (MRI), the right striatum was hyperintense on
T1-weighted images without contrast administration, sug-
gestive of diabetic striatopathy. Focal hyperintensity on
diffusion-weighted imaging within the right centrum
semiovale suggested the presence of an associated recent
ischemic stroke (Figure 1).
Diabetes mellitus decompensation, with fasting glu-
cose levels reaching 540 mg/dL during the hospital stay,
was treated with insulin, and platelet antiaggregation ther-
apy for stroke treatment and recurrence prevention was
started. As soon as blood glucose decreased toward normal
values, hemichorea gradually subsided, making symptom-
atic treatment unnecessary; dramatic cognitive and motor
improvement were obtained at discharge.
Clinical and MRI follow-up were performed. Hypersig-
nal of right lenticular and caudate nuclei and recurrence of
left hemichorea were evident until 9 months later in a
context of not-yet-satisfactory glycemic control (HbA1c
9.1%). Imaging and clinical findings had disappeared at 24-
month follow-up, when better control of diabetes mellitus
was evident (HbA1c 8.3%), reinforcing the diagnosis of
hyperglycemic hemichorea. He had three recurrent strokes
during 24 months of follow-up in the deep territory of the
left middle cerebral artery, the right cerebellar hemisphere,
and the left medulla oblongata and right corona radiata.
This individual was characterized by the overlap of
diabetic decompensation with hemichoreic symptomatol-
ogy and ischemic stroke manifesting with confusion and
postural instability. Hemichorea was recurrent during the
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Figure 1. Brain magnetic resonance imaging revealing (A) T1-
weighted hyperintensity of the right basal ganglia and (B) a
diffusion-weighted hypersignal in the right centrum semiovale.
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9-month period of persistence of basal ganglia abnormali-
ties in the context of poor glycemic control. Diabetic
striatopathy is a well-recognized but rare cause of hemibal-
lism-hemichorea, associated with contralateral basal
ganglia hyperdensity on CT and hyperintensity on T1-
weighted MRI.1–4 The cause of clinical and imaging
abnormalities is unclear. Several mechanisms attributed to
hyperglycemia have been proposed: transient ischemic
injury with microhemorrhage resulting in hyperviscosity
caused by hyperosmotic state, calcium deposition, gemisto-
cytosis, altered GABAergic and dopaminergic neurotrans-
mission,5–8 paramagnetic mineral deposition including
zinc-containing metallothionein expressed in swollen astro-
cytes,9 and autoimmunity-mediated inflammation.10
This was the first case, to the authors’ knowledge, of
contemporary occurrence of hyperglycemia-related hemi-
chorea and stroke. Two possible diagnostic hypothesis
were taken into account: the first considered stroke to have
played a central role in diabetes mellitus decompensation,
which, in a context of cerebral frailty due to stroke, led to
the development of hyperglycemia-related hemiballism-
hemichorea; the second considered hyperglycemia as the
trigger of stroke through an ischemic injury due to hyper-
viscosity.5 The available anamnestic data did not help
identify which of the two disorders first appeared. The
proximity of the stroke lesion to the altered basal ganglia,
both in the right middle cerebral artery area, is interesting;
although this strengthens the hypothesis of the ischemic
mechanism for imaging abnormalities associated to hyper-
glycemia, it seems in accord with the second hypothesis. It
could also be related to the first hypothesis, if the abnor-
mal basal ganglia is considered to enter the ischemic
penumbra of the documented stroke. Moreover, a partici-
pating direct role of the documented ischemic stroke to the
abnormal movements cannot be excluded given the exis-
tence also of vascular hemichorea-hemiballism typically
associated with lesions of the basal ganglia and, as in this
case, of the adjacent white matter.1
Difficulties in optimal glycemic control probably
contributed to the persistence for several months of basal
ganglia abnormalities accompanied by recurrence of hemi-
chorea, both finally disappearing 24 months later when
diabetes mellitus compensation was also evident.
Hyperglycemia-related hemiballism-hemichorea and the
occurrence of four ischemic strokes during a 24-month per-
iod are rare in clinical practice. This man’s case raises doubts
also about the possible predictive role of hyperglycemia-
related hemiballism-hemichorea for recurrence of stroke.
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COMMENTS/RESPONSES
GUIDELINES FOR THE CLINICAL DIAGNOSIS OF
DIABETES MELLITUS–RELATED DEMENTIA
To the Editor: Type 2 diabetes mellitus (DM) has been
shown to increase the risk of cognitive decline and demen-
tia, such as Alzheimer’s disease (AD) and vascular demen-
tia.1 Several mechanistic studies have indicated that
vascular disease, glucose toxicity, and changes in insulin
and amyloid metabolism underlie the pathophysiology of
dementia.2 A dementia subgroup with characteristics
predominantly associated with DM-related metabolic
abnormalities rather than AD or vascular pathology was
identified in individuals with dementia associated with
DM.3 This type of dementia, showing neither cerebrovas-
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